Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

34.9900 USD 1.1500 3.40%

As of 12:22:55 ET on 03/02/2015.

Company Profile for Acorda Therapeutics Inc (ACOR)

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Contact Information

Acorda Therapeutics Inc

420 Saw Mill River Road
Ardsley, NY 10502
United States
Phone: 1-914-347-4300
Fax: 1-914-347-4560

Key Executives for Acorda Therapeutics Inc (ACOR)

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
Andrew R Blight "Andy"Chief Scientific OfficerDavid LawrenceChief:Business Operations
Jane WasmanPres:Intl/Secy/Gen CnslLauren M SabellaExec VP:Commercial Dev
Jeff MacdonaldSenior Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil